Baxter/BAX

$41.94

-1.43%
-
1D1W1MYTD1YMAX

About Baxter

Baxter International Inc., through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s Medical Products and Therapies segment includes sales of sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant and adhesion prevention products. Its Healthcare Systems and Technologies segment includes connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices and advanced equipment for the surgical space, including surgical video technologies and precision positioning devices. Its Pharmaceuticals segment includes specialty injectable pharmaceuticals, inhaled anesthesia and drug compounding. Its Kidney Care segment includes chronic and acute dialysis therapies and services, including peritoneal dialysis, hemodialysis, continuous renal replacement therapies (CRRT) and other organ support therapies.

Ticker

BAX

Sector

Healthcare

Trading on

NYSE

Industry

Medical Equipment & Supplies

CEO

Jose Almeida

Employees

60,000

Headquarters

Deerfield, United States

Baxter Metrics

BasicAdvanced
$21.61B
Market cap
8.15
P/E ratio
$5.22
EPS
0.63
Beta
$1.16
Dividend rate
2.73%
Dividend yield

What the Analysts think about Baxter

Analyst Ratings

Majority rating from 16 analysts.
Hold

Price Targets

Average projection from 12 analysts.
7.7% upside
High $54.00
Low $39.00
$41.94
Current price
$45.17
Average price target

Baxter Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
6.3% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$3.89B
4.77%
Net income
$245M
-90.23%
Profit margin
6.3%
-90.68%

Baxter Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 1.82%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.55
$0.68
$0.88
-
-
Expected
$0.61
$0.67
$0.86
$0.61
$0.71
Surprise
-9.54%
1.84%
1.82%
-
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Baxter stock

Buy or sell Baxter stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing